Semaphorin3A: A potential therapeutic tool in immune-mediated diseases

von Vadasz, Zahava, Toubi, Elias
Veröffentlicht in Eur J Rheumatol (2018)

The Emerging Role of IL-17 in the Immune-Pathogenesis of Chronic Spontaneous Urticaria

von Toubi, Elias, Vadasz, Zahava
Veröffentlicht in Immunotargets Ther (2020)

Hierarchical Involvement of Myeloid-Derived Suppressor Cells and Monocytes Expressing Latency-Associated Peptide in Plasma Cell Dyscrasias

von Tadmor, Tamar, Levy, Ilana, Vadasz, Zahava
Veröffentlicht in Turk J Haematol (2018)

Immune-Mediated Coagulopathy in COVID-19 Infection

von Vadasz, Zahava, Brenner, Benjamin, Toubi, Elias
Veröffentlicht in Semin Thromb Hemost (2020)

Age-related autoimmunity

von Vadasz, Zahava, Haj, Tharwat, Kessel, Aharon, Toubi, Elias
Veröffentlicht 2013

Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure?

von Willner, Nadav, Goldberg, Yair, Schiff, Elad, Vadasz, Zahava
Veröffentlicht in ESC Heart Fail (2018)

Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence

von Metz, Martin, Vadasz, Zahava, Kocatürk, Emek, Giménez-Arnau, Ana M.
Veröffentlicht in Clin Rev Allergy Immunol (2020)

The Expansion of CD25(high)IL-10(high)FoxP3(high) B Regulatory Cells Is in Association with SLE Disease Activity

von Vadasz, Zahava, Peri, Regina, Eiza, Nasren, Slobodin, Gleb, Balbir-Gurman, Alexandra, Toubi, Elias
Veröffentlicht in J Immunol Res (2015)

The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)

von Vadasz, Zahava, Rainis, Tova, Nakhleh, Afif, Haj, Tharwat, Bejar, Jacob, Halasz, Katty, Toubi, Elias
Veröffentlicht in PLoS One (2015)

Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis

von Bejar, Jacob, Kessler, Ofra, Sabag, Adi D., Sabo, Edmond, Itzhak, Ofer Ben, Neufeld, Gera, Vadasz, Zahava
Veröffentlicht in Front Immunol (2018)

Expression of Semaphorin 3A in Malignant and Normal Bladder Tissue: Immunohistochemistry Staining and Morphometric Evaluation

von Bejar, Ilan, Rubinstein, Jacob, Bejar, Jacob, Sabo, Edmond, Sheffer, Hilla K, Bahouth, Zaher, Halachmi, Sarel, Vadasz, Zahava
Veröffentlicht in Biology (Basel) (2021)

Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma

von Adi, Sabag D., Eiza, Nasren, Bejar, Jacob, Shefer, Hila, Toledano, Shira, Kessler, Ofra, Neufeld, Gera, Toubi, Elias, Vadasz, Zahava
Veröffentlicht in Front Immunol (2019)

Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus

von Vadasz, Zahava, Haj, Tharwat, Halasz, Katalin, Rosner, Itzhak, Slobodin, Gleb, Attias, Dina, Kessel, Aharon, Kessler, Ofra, Neufeld, Gera, Toubi, Elias
Veröffentlicht 2012

Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019

von Barkama, Ravit, Mayo, Ami, Paz, Alona, Solopov, Anna, Mann, Tal, Vadasz, Zahava, Appel, Tal, Ofir, Racheli, Shani, Liran, Sheleg, Michal, Allen, Hoshea, Shaked Nitzan, Rony, Tsarfaty, Nurit, Gilad, Hadar, Birch, Thomas, Kachel, Erez, Reinke, Petra, Volk, Hans-Dieter, Zalts, Ronen, Raz Pasteur, Ayelet
Veröffentlicht in Crit Care Explor (2020)